A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer

Tomotaka Saito,Yousuke Nakai,Hiroyuki Isayama,Kenji Hirano,Kazunaga Ishigaki,Ryunosuke Hakuta,Tsuyoshi Takeda,Kei Saito,Gyotane Umefune,Dai Akiyama,Takeo Watanabe,Kaoru Takagi,Naminatsu Takahara,Tsuyoshi Hamada,Rie Uchino,Suguru Mizuno,Dai Mouri,Hiroshi Yagioka,Hirofumi Kogure,Osamu Togawa,Saburo Matsubara,Yukiko Ito,Natsuyo Yamamoto,Minoru Tada,Kazuhiko Koike

A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer

2018

ObjectiveExocrine pancreatic insufficiency may impair the nutritional status in pancreatic cancer (PC), but the role of pancreatic enzyme replacement therapy (PERT) is not fully evaluated. Therefore, we conducted this multicenter open-label randomized controlled trial to evaluate the role of PERT in

Keywords:

Endocrinology
Internal medicine
Randomized controlled trial
Gastroenterology
Unresectable Pancreatic Cancer
Biology
Enzyme replacement therapy
Diabetes mellitus
Pancreatic cancer
nutritional status
pancreatic enzymes
Body mass index
Oncology
open label

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations